These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 16333938

  • 1. Efficacy and outcomes of clarithromycin treatment for pulmonary MAC disease.
    Fujikane T, Fujiuchi S, Yamazaki Y, Sato M, Yamamoto Y, Takeda A, Nishigaki Y, Fujita Y, Shimizu T.
    Int J Tuberc Lung Dis; 2005 Nov; 9(11):1281-7. PubMed ID: 16333938
    [Abstract] [Full Text] [Related]

  • 2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ, Wu TS, Chiang PC, Lee MH.
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [Abstract] [Full Text] [Related]

  • 3. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
    Watanabe M, Hasegawa N, Ishizaka A, Asakura K, Izumi Y, Eguchi K, Kawamura M, Horinouchi H, Kobayashi K.
    Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
    [Abstract] [Full Text] [Related]

  • 4. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
    Roussel G, Igual J.
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):462-70. PubMed ID: 9626603
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens].
    Shirai M, Hayakawa H, Nakano Y, Kuroishi S, Nakano Y, Todate A, Suda T, Chida K.
    Nihon Kokyuki Gakkai Zasshi; 2004 Oct; 42(10):875-9. PubMed ID: 15566000
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K, Ebe T.
    Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease.
    Ito Y, Hirai T, Maekawa K, Fujita K, Imai S, Tatsumi S, Handa T, Matsumoto H, Muro S, Niimi A, Mishima M.
    Int J Tuberc Lung Dis; 2012 Jul; 16(3):408-14. PubMed ID: 22230733
    [Abstract] [Full Text] [Related]

  • 17. [The short-term effects of multidrug chemotherapy for pulmonary Mycobacterium avium-intracellulare complex (MAC) infection].
    Kurashima A.
    Kekkaku; 1998 May; 73(5):371-7. PubMed ID: 9637822
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical analysis of drug interaction between rifampicin and clarithromycin which are used for treating pulmonary Mycobacterium avium complex infection].
    Taki H, Ogawa K, Nakagawa T, Kashima K, Tarumi O, Saitou Y, Yamada N, Tano M, Nikai T.
    Kekkaku; 2007 Aug; 82(8):641-6. PubMed ID: 17874572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.